METHOTREXATE Side Effects

7020339-3 | Leukoencephalopathy
on Sep 21, 2010 Male patient from UNITED STATES , 14 years of age, was diagnosed with leukaemia and was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: leukoencephalopathy. Methotrexate dosage: Intrathecal.

7019845-7 | Apgar Score Low, Caesarean Section, Premature Baby, Small For Dates Baby
Patient was taking Methotrexate (View Usage). Patient had the following side effects: apgar score low, caesarean section, premature baby, small for dates baby on Sep 14, 2010 from TURKEY Additional patient health information: Male patient , weighting 2.09 lb, . Methotrexate dosage: Transplacental. During the same period patient was treated with LEFLUNOMIDE (Transplacental) (View Leflunomide Review and Leflunomide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CHOLESTYRAMINE (View Cholestyramine Review and Cholestyramine Label ). Patient was hospitalized.

7018184-8 | Caesarean Section, Premature Rupture Of Membranes, Treatment Noncompliance
Adverse event was reported on Sep 14, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: 20 Mg/week) was diagnosed with still's disease adult onset and. Location: TURKEY , 23 years of age, After Methotrexate was administered, patient had the following side effects: caesarean section, premature rupture of membranes, treatment noncompliance. During the same period patient was treated with LEFLUNOMIDE (20 Mg Milligram(s), Day) (View Leflunomide Review and Leflunomide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

7016794-5 | Anal Abscess, Gastroenteritis Pseudomonas, Pseudomonas Infection, Subcutaneous Abscess, Viith Nerve Paralysis
on Sep 24, 2010 Female patient from , child 1 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: anal abscess, gastroenteritis pseudomonas, pseudomonas infection, subcutaneous abscess, viith nerve paralysis. Methotrexate dosage: . During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ).


7011871-7 | Encephalopathy
on Sep 10, 2010 Female patient from FRANCE , 56 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Methotrexate (View Usage). Patient had the following side effects: encephalopathy. Methotrexate dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEPOCYT (View Depocyt Review and Depocyt Label ), HOLOXAN (View Holoxan Review and Holoxan Label ), NOVANTRONE (View Novantrone Review and Novantrone Label ), MABTHERA (View Mabthera Review and Mabthera Label ). Patient was hospitalized.

7010545-6 | Dermatitis Bullous, Neutropenia, Palmar-plantar Erythrodysaesthesia Syndrome
Patient was taking Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: dermatitis bullous, neutropenia, palmar-plantar erythrodysaesthesia syndrome on Sep 22, 2010 from Additional patient health information: Male patient , child 12 years of age, was diagnosed with acute lymphocytic leukaemia recurrent and. Methotrexate dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ELSPAR (View Elspar Review and Elspar Label ), THIOGUANINE (View Thioguanine Review and Thioguanine Label ). Patient was hospitalized.

7008073-7 | Hepatomegaly, Hypergammaglobulinaemia, Leukopenia, Splenomegaly, Visceral Leishmaniasis
Adverse event was reported on Sep 07, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: GREECE , 79 years of age, Patient experienced the following unwanted or unexpected effects: hepatomegaly, hypergammaglobulinaemia, leukopenia, splenomegaly, visceral leishmaniasis.

7006605-6 | Asthenia, Erythema, Febrile Neutropenia, Haemorrhoids, Jaundice, Mucosal Inflammation, Oral Pain, Oropharyngeal Pain, Pyrexia
on Sep 21, 2010 Male patient from UNITED STATES , weighting 175.9 lb, was treated with Methotrexate (View Usage). Patient had the following side effects: asthenia, erythema, febrile neutropenia, haemorrhoids, jaundice (What is jaundice?), mucosal inflammation, oral pain, oropharyngeal pain, pyrexia. Methotrexate dosage: 915 Mg. During the same period patient was treated with PEG L ASPARAGINASE (K H) (10000 Mg) (View Peg-l- Asparaginase (k -h) Review and Peg-l- Asparaginase (k -h) Label ), VINCRISTINE SULFATE (3 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ). Patient was hospitalized.

6992496-6 | Acute Respiratory Distress Syndrome, Anaemia, Cardiac Arrest, Dehydration, Ischaemic Hepatitis, Leukopenia, Metabolic Acidosis, Neutropenia, Renal Failure Acute
on Sep 16, 2010 Female patient from UNITED STATES , 56 years of age, weighting 143.0 lb, was diagnosed with psoriasis and was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: acute respiratory distress syndrome, anaemia, cardiac arrest (What is cardiac arrest?), dehydration, ischaemic hepatitis, leukopenia, metabolic acidosis, neutropenia, renal failure acute. Methotrexate dosage: 12.5 Mg Once Im.

6987204-9 | Diffuse Large B-cell Lymphoma, Lung Infiltration, Pleural Effusion
Patient was taking Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: diffuse large b-cell lymphoma, lung infiltration, pleural effusion on Sep 08, 2010 from Additional patient health information: Female patient , 70 years of age, was diagnosed with psoriatic arthropathy and. Methotrexate dosage: .

6982073-5 | Arthritis Bacterial, Joint Effusion, Musculoskeletal Pain
Adverse event was reported on Aug 24, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: 7857 Mg (12.5 Mg, 1 In 1 Wk)) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: NEW ZEALAND , 88 years of age, Patient had the following side effects: arthritis bacterial, joint effusion, musculoskeletal pain. During the same period patient was treated with PREDNISONE (PREDNISONE) (PREDNISONE) (View Prednisone (prednisone) (prednisone) Review and Prednisone (prednisone) (prednisone) Label ), HYDROCORTISONE (HYDROCORTISONE) (HYDROCORTISONE) (View Hydrocortisone (hydrocortisone) (hydrocortisone) Review and Hydrocortisone (hydrocortisone) (hydrocortisone) Label ). Patient was hospitalized.

6981859-0 | Back Pain, Epstein-barr Virus Infection
on Aug 04, 2010 Male patient from JAPAN , 60 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: back pain (What is back pain?), epstein-barr virus infection. Methotrexate dosage: 1.1429 Mg, 1 In 1 Wk.

6971893-9 | Enterobacter Test Positive, Neutropenia, Septic Shock
on Sep 08, 2010 Male patient from UNITED STATES , weighting 72.75 lb, was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: enterobacter test positive, neutropenia, septic shock. Methotrexate dosage: 60 Mg. During the same period patient was treated with VINCRISTINE SULFATE (1.7 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DEXAMETHASONE (32.5 Mg) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6971493-0 | Haemorrhagic Diathesis, Platelet Count Decreased, Stomatitis
Patient was taking Methotrexate (View Usage). Patient had the following side effects: haemorrhagic diathesis, platelet count decreased, stomatitis on Aug 25, 2010 from JAPAN Additional patient health information: Female patient , 73 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Methotrexate dosage: . During the same period patient was treated with FOLIAMIN (View Foliamin Review and Foliamin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CELECOX (View Celecox Review and Celecox Label ), CELOOP (View Celoop Review and Celoop Label ).

6969505-3 | Hepatic Cirrhosis, Serum Ferritin Increased
Adverse event was reported on Sep 07, 2010 by a Male patient taking Methotrexate (View Usage) (Dosage: ) . Location: UNITED STATES , 20 years of age, weighting 209.4 lb, After Methotrexate was administered, patient had the following side effects: hepatic cirrhosis, serum ferritin increased. During the same period patient was treated with MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ). Patient was hospitalized.

6969504-1 | Hepatic Cirrhosis, Hepatitis
on Sep 07, 2010 Male patient from UNITED STATES , weighting 209.2 lb, was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic cirrhosis, hepatitis (What is hepatitis?). Methotrexate dosage: . During the same period patient was treated with MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), ACTIGALL (View Actigall Review and Actigall Label ), NEXIUM (View Nexium Review and Nexium Label ), DAPSONE (View Dapsone Review and Dapsone Label ).

6969416-3 | Asymptomatic Bacteriuria, Diabetes Mellitus, Diarrhoea, Disseminated Intravascular Coagulation, Emphysematous Pyelonephritis, Enterocolitis, Haemodialysis, Hypotension, Shock
on Aug 17, 2010 Female patient from JAPAN , 72 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). Patient had the following side effects: asymptomatic bacteriuria, diabetes mellitus, diarrhoea, disseminated intravascular coagulation, emphysematous pyelonephritis, enterocolitis, haemodialysis, hypotension, shock. Methotrexate dosage: (4 Mg, 4 Mg/week). During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6964106-5 | Pancytopenia, Retinal Exudates
Patient was taking Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: pancytopenia, retinal exudates on Aug 23, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Methotrexate dosage: 12.5mg Once Weekly. During the same period patient was treated with FOLIC ACID (1 Mg/day) (View Folic Acid Review and Folic Acid Label ).

6963674-7 | Lung Infiltration, Multi-organ Failure, Renal Failure
Adverse event was reported on Aug 11, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: (2000 Mg/m2,over 20 Hours)) was diagnosed with acute lymphocytic leukaemia and. Location: INDIA , 14 years of age, Patient experienced the following unwanted or unexpected effects: lung infiltration, multi-organ failure, renal failure.

6961579-9 | Faecal Incontinence, Gastrointestinal Toxicity, Myelopathy, Pancytopenia, Paraparesis, Urinary Incontinence
on Aug 18, 2010 Female patient from GERMANY , 54 years of age, was diagnosed with breast cancer metastatic and was treated with Methotrexate (View Usage). Patient had the following side effects: faecal incontinence, gastrointestinal toxicity, myelopathy, pancytopenia, paraparesis, urinary incontinence (What is urinary incontinence?). Methotrexate dosage: Four Cycles Of Methotrexate 15mg Every 5 Days. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized and became disabled.

6960404-X | Faecal Incontinence, Muscular Weakness, Polyneuropathy, Urinary Incontinence
on Aug 18, 2010 Female patient from GERMANY , weighting 132.3 lb, was diagnosed with metastases to central nervous system and was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: faecal incontinence, muscular weakness, polyneuropathy, urinary incontinence (What is urinary incontinence?). Methotrexate dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ), THIOTEPA (View Thiotepa Review and Thiotepa Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ).

6960094-6 | Diarrhoea Haemorrhagic, Myelopathy, Pancytopenia, Urinary Retention, Vomiting
Patient was taking Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea haemorrhagic, myelopathy, pancytopenia, urinary retention, vomiting on Aug 23, 2010 from GERMANY Additional patient health information: Female patient , 54 years of age, . Methotrexate dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6958996-X | Lung Neoplasm
Adverse event was reported on Aug 17, 2010 by a Male patient taking Methotrexate (View Usage) (Dosage: 12.5 Mg Weekly) was diagnosed with psoriatic arthropathy and. Location: UNITED KINGDOM , 64 years of age, Patient had the following side effects: lung neoplasm. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), INSULIN (View Insulin Review and Insulin Label ).

6958954-5 | Disseminated Intravascular Coagulation, Emphysematous Pyelonephritis, Shock
on Aug 17, 2010 Female patient from JAPAN , 72 years of age, was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: disseminated intravascular coagulation, emphysematous pyelonephritis, shock. Methotrexate dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6958845-X | Anuria, Asymptomatic Bacteriuria, Dehydration, Diabetes Mellitus, Disseminated Intravascular Coagulation, Emphysematous Pyelonephritis, Shock
on Aug 24, 2010 Female patient from , 72 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: anuria, asymptomatic bacteriuria, dehydration, diabetes mellitus, disseminated intravascular coagulation, emphysematous pyelonephritis, shock. Methotrexate dosage: . During the same period patient was treated with PREDNISOLONE (15 Mg) (View Prednisolone Review and Prednisolone Label ).

6958585-7 | Faecal Incontinence, Gastrointestinal Toxicity, Haematotoxicity, Myelopathy, Neutropenia, Paraparesis, Urinary Retention
Patient was taking Methotrexate (View Usage). Patient had the following side effects: faecal incontinence, gastrointestinal toxicity, haematotoxicity, myelopathy, neutropenia, paraparesis, urinary retention on Aug 24, 2010 from Additional patient health information: Female patient , 54 years of age, was diagnosed with metastases to meninges and. Methotrexate dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ). Patient was hospitalized.

6942332-9 | Apgar Score Low, Foetal Distress Syndrome, Grand Mal Convulsion, Holoprosencephaly, Hydronephrosis, Penis Deviation, Premature Baby, Vesicoureteric Reflux
Adverse event was reported on Aug 23, 2010 by a Male patient taking Methotrexate (View Usage) (Dosage: 5 Mg) . Location: , weighting 4.41 lb, After Methotrexate was administered, patient had the following side effects: apgar score low, foetal distress syndrome, grand mal convulsion, holoprosencephaly, hydronephrosis, penis deviation, premature baby, vesicoureteric reflux. During the same period patient was treated with AMPICILLIN SODIUM (View Ampicillin Sodium Review and Ampicillin Sodium Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6942193-8 | Cytomegalovirus Mononucleosis, Rheumatoid Arthritis
on Aug 23, 2010 Female patient from , 35 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus mononucleosis, rheumatoid arthritis (What is rheumatoid arthritis?). Methotrexate dosage: . During the same period patient was treated with INFLIXIMAB (View Infliximab Review and Infliximab Label ). Patient was hospitalized.

6941436-4 | Pulmonary Tuberculosis
on Aug 16, 2010 Male patient from SERBIA , 14 years of age, was diagnosed with acute lymphocytic leukaemia, pneumonia (What is pneumonia?) and was treated with Methotrexate (View Usage). Patient had the following side effects: pulmonary tuberculosis. Methotrexate dosage: . During the same period patient was treated with MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CLOXACILLIN (View Cloxacillin Review and Cloxacillin Label ). Patient was hospitalized.

6941108-6 | Pancytopenia, Retinal Exudates
Patient was taking Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: pancytopenia, retinal exudates on Aug 23, 2010 from Additional patient health information: Female patient , 52 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Methotrexate dosage: . During the same period patient was treated with FOLIC ACID (1 Mg) (View Folic Acid Review and Folic Acid Label ).

6938044-8 | Abdominal Pain, Ascites, Blood Pressure Decreased, Hepatic Failure, Mucosal Inflammation, Multi-organ Failure, Renal Failure, Respiratory Distress
Adverse event was reported on Aug 23, 2010 by a Male patient taking Methotrexate (View Usage) (Dosage: 20 Mg) . Location: UNITED STATES , weighting 168.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), ascites, blood pressure decreased, hepatic failure, mucosal inflammation, multi-organ failure, renal failure, respiratory distress. During the same period patient was treated with SIROLIMUS (View Sirolimus Review and Sirolimus Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

6938021-7 | Condition Aggravated, Psoriasis
on Aug 12, 2010 Male patient from UNITED KINGDOM , 64 years of age, was diagnosed with nail psoriasis and was treated with Methotrexate (View Usage). Patient had the following side effects: condition aggravated, psoriasis. Methotrexate dosage: 12.5 Mg Milligram(s), 1 Week, Oral. During the same period patient was treated with VARENICLINE TARTRATE (View Varenicline Tartrate Review and Varenicline Tartrate Label ).

6937015-5 | Dyspepsia, Encephalopathy
on Aug 18, 2010 Male patient from , 50 years of age, was diagnosed with psoriatic arthropathy and was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: dyspepsia, encephalopathy. Methotrexate dosage: . Patient was hospitalized.

6936015-9 | Bradycardia
Patient was taking Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia on Aug 19, 2010 from UNITED STATES Additional patient health information: Male patient , 83 years of age, weighting 228.0 lb, was diagnosed with bladder cancer (What is bladder cancer?) and. Methotrexate dosage: First 3 Were Given Ivp. During the same period patient was treated with VINBLASTINE SULFATE (First 3 Were Given Ivp) (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CISPLATIN (Iv) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6933613-3 | Acute Respiratory Distress Syndrome, Disseminated Intravascular Coagulation, Disseminated Tuberculosis, Multi-organ Failure, Respiratory Failure
Adverse event was reported on Aug 18, 2010 by a Male patient taking Methotrexate (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), acute interstitial pneumonitis, disseminated tuberculosis and. Location: , 62 years of age, weighting 132.3 lb, Patient had the following side effects: acute respiratory distress syndrome, disseminated intravascular coagulation, disseminated tuberculosis, multi-organ failure, respiratory failure. During the same period patient was treated with PARAMETHASONE ACETATE (1 Mg) (View Paramethasone Acetate Review and Paramethasone Acetate Label ), BUCILLAMINE (300 Mg) (View Bucillamine Review and Bucillamine Label ), METHYLPREDNISOLONE (1 G) (View Methylprednisolone Review and Methylprednisolone Label ), CIPROFLOXACIN (600 Mg) (View Ciprofloxacin Review and Ciprofloxacin Label ), ISONIAZID (300 Mg) (View Isoniazid Review and Isoniazid Label ), STREPTOMYCIN HYDROCHLORIDE (1 G) (View Streptomycin Hydrochloride Review and Streptomycin Hydrochloride Label ).

6930385-3 | Malignant Melanoma
on Aug 04, 2010 Female patient from UNITED KINGDOM , 34 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: malignant melanoma. Methotrexate dosage: 20 Mg Milligram(s) 1 Week Oral. During the same period patient was treated with HUMIRA (Subcutaneous) (View Humira Review and Humira Label ).

6929302-1 | Lung Neoplasm
on Aug 09, 2010 Male patient from UNITED KINGDOM , 64 years of age, was diagnosed with psoriatic arthropathy and was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: lung neoplasm. Methotrexate dosage: .

6929298-2 | Psoriasis
Patient was taking Methotrexate (View Usage). Patient had the following side effects: psoriasis on Aug 13, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 64 years of age, was diagnosed with nail psoriasis and. Methotrexate dosage: . During the same period patient was treated with VARENICLINE TARTRATE (View Varenicline Tartrate Review and Varenicline Tartrate Label ).

6929005-3 | Pancytopenia
Adverse event was reported on Aug 12, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: 15 Mg, Qw) was diagnosed with polyarthritis, osteoporosis (What is osteoporosis?) and. Location: GERMANY , 87 years of age, After Methotrexate was administered, patient had the following side effects: pancytopenia. During the same period patient was treated with FOSAVANCE (View Fosavance Review and Fosavance Label ), FOLSAEURE ^HEVERT^ (View Folsaeure ^hevert^ Review and Folsaeure ^hevert^ Label ), NOVAMINSULFON ^BRAUN^ (View Novaminsulfon ^braun^ Review and Novaminsulfon ^braun^ Label ).

6925813-3 | Blood Cholesterol Increased, Blood Triglycerides Increased, Neutrophil Count Abnormal
on Aug 13, 2010 Male patient from UNITED STATES , weighting 143.1 lb, was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: blood cholesterol increased, blood triglycerides increased, neutrophil count abnormal. Methotrexate dosage: . During the same period patient was treated with ONCASPAR (6750 Mg) (View Oncaspar Review and Oncaspar Label ), VINCRISTINE SULFATE (10 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ).

6918133-4 | Pneumonia Pneumococcal
on Jul 26, 2010 Female patient from UNITED STATES , 78 years of age, weighting 189.8 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). Patient had the following side effects: pneumonia pneumococcal. Methotrexate dosage: . During the same period patient was treated with PREDNISONE (10 Mg, Once A Day, Oral) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6917644-5 | Vomiting, Wernicke's Encephalopathy, Wernicke-korsakoff Syndrome
Patient was taking Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: vomiting, wernicke's encephalopathy, wernicke-korsakoff syndrome on Jul 27, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 62 years of age, was diagnosed with central nervous system lymphoma, sepsis (What is sepsis?) and. Methotrexate dosage: Dosage And Route Not Stated. During the same period patient was treated with CYTARABINE (Dosage And Route Not Stated) (View Cytarabine Review and Cytarabine Label ), DOXYCYCLINE (Dosage And Route Not Stated) (View Doxycycline Review and Doxycycline Label ), FUSIDIC ACID (Dosage And Route Not Stated) (View Fusidic Acid Review and Fusidic Acid Label ), VANCOMYCIN (Dosage And Route Not Stated) (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6917643-3 | Vomiting, Wernicke's Encephalopathy, Wernicke-korsakoff Syndrome
Adverse event was reported on Jul 27, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: Dosage And Route Not Stated) was diagnosed with central nervous system lymphoma, sepsis (What is sepsis?) and. Location: UNITED KINGDOM , 62 years of age, Patient experienced the following unwanted or unexpected effects: vomiting, wernicke's encephalopathy, wernicke-korsakoff syndrome. During the same period patient was treated with CYTARABINE (Dosage And Route Not Stated) (View Cytarabine Review and Cytarabine Label ), DOXYCYCLINE (Dosage And Route Not Stated) (View Doxycycline Review and Doxycycline Label ), FUSIDIC ACID (Dosage And Route Not Stated) (View Fusidic Acid Review and Fusidic Acid Label ), VANCOMYCIN (Dosage And Route Not Stated) (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6908460-9 | Nephropathy Toxic
on Aug 02, 2010 Male patient from , 14 years of age, was diagnosed with non-hodgkin's lymphoma, ph urine abnormal and was treated with Methotrexate (View Usage). Patient had the following side effects: nephropathy toxic. Methotrexate dosage: . During the same period patient was treated with GLUTAMINE (20 G) (View Glutamine Review and Glutamine Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ).

6907707-2 | Hypomagnesaemia, Hypophagia, Multi-organ Failure, Nausea, Sepsis, Wernicke's Encephalopathy, Wernicke-korsakoff Syndrome
on Aug 02, 2010 Female patient from , 62 years of age, was diagnosed with central nervous system lymphoma, sepsis (What is sepsis?), wernicke's encephalopathy and was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: hypomagnesaemia, hypophagia, multi-organ failure, nausea (What is nausea?), sepsis (What is sepsis?), wernicke's encephalopathy, wernicke-korsakoff syndrome. Methotrexate dosage: . During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), FUSIDIC ACID (View Fusidic Acid Review and Fusidic Acid Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), THIAMINE (View Thiamine Review and Thiamine Label ). Patient was hospitalized.

6906548-X | Recall Phenomenon
Patient was taking Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: recall phenomenon on Aug 02, 2010 from Additional patient health information: Female patient , 26 years of age, was diagnosed with ectopic pregnancy and. Methotrexate dosage: 50 Mg.

6905416-7 | Incorrect Product Storage
Adverse event was reported on Jul 21, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: 0.9ml Subcutaneously, Once Weekly) . Location: UNITED STATES , 60 years of age, Patient had the following side effects: incorrect product storage.

6902159-0 | Asthenia, Diarrhoea, Febrile Neutropenia, Renal Failure Acute, Sepsis
on Aug 02, 2010 Male patient from UNITED STATES , 84 years of age, was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: asthenia, diarrhoea, febrile neutropenia, renal failure acute, sepsis (What is sepsis?). Methotrexate dosage: 15 Mg Once Other. During the same period patient was treated with ADALIMUMAB (Once Sq) (View Adalimumab Review and Adalimumab Label ). Patient was hospitalized.

6883463-1 | Blood Creatinine Increased, Blood Urea Increased
on Jul 20, 2010 Female patient from POLAND , weighting 158.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased. Methotrexate dosage: 10 Mg/week.

6867751-0 | Pain
Patient was taking Methotrexate (View Usage). Patient had the following side effects: pain (What is pain?) on Jul 09, 2010 from GERMANY Additional patient health information: Female patient , 69 years of age, . Methotrexate dosage: . During the same period patient was treated with ANALGESICS (View Analgesics Review and Analgesics Label ).